SCHEMBL21035619

SCHEMBL21035619

CC(C)(C)OC(=O)NC1CC2CCC(C1)N2C(=O)[C@@H]1CC(Nc2ccc(Cl)cc2)CN1S(=O)(=O)c1ccc2cc(OC3CCCC3)ccc2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP9 P14780 8/20 0.37
MMP2 P08253 7/20 0.37
KMT2A Q03164 2/20 0.35
MMP3 P08254 3/20 0.35
MMP1 P03956 2/20 0.35
MMP7 P09237 1/20 0.35
MMP13 P45452 1/20 0.35
GPR119 Q8TDV5 2/20 0.34
RORC P51449 2/20 0.34
CACNB4 O00305 1/20 0.34
CACNA1A O00555 1/20 0.34
CACNA1G O43497 1/20 0.34
CACNG3 O60359 1/20 0.34
CACNA1F O60840 1/20 0.34
CACNA1H O95180 1/20 0.34
CACNB3 P54284 1/20 0.34
CACNA2D1 P54289 1/20 0.34
CACNG7 P62955 1/20 0.34
CACNA1B Q00975 1/20 0.34
CACNA1D Q01668 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21035404 0.92 MMP9 (0.36) MMP9MMP2KMT2AMMP3MMP1
SCHEMBL21035316 0.92 MMP9 (0.36) MMP9MMP2KMT2AMMP3MMP1
SCHEMBL21035667 0.88 ITGB1 (0.39) KMT2AGPR119CACNB4CACNA1ACACNA1G
SCHEMBL21035615 0.88 GHSR (0.38) MMP9MMP2MMP3MMP1MMP7
SCHEMBL21035612 0.88 GHSR (0.38) MMP9MMP2MMP3MMP1MMP7
SCHEMBL21035614 0.88 GHSR (0.38) MMP9MMP2MMP3MMP1MMP7
SCHEMBL21035008 0.87 ITGB1 (0.38) KMT2AGPR119CACNB4CACNA1ACACNA1G
SCHEMBL21035131 0.87 ITGB1 (0.38) KMT2AGPR119CACNB4CACNA1ACACNA1G
SCHEMBL21035520 0.85 L3MBTL1 (0.39) MMP9MMP2KMT2AMMP3MMP1
SCHEMBL21036232 0.85 CCR4 (0.38) MMP9KMT2AMMP3MMP1MMP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019104011-A1 CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2019-05-31 WO disclosed